| scholarly article | Q13442814 |
| P50 | author | Himanshu Kathuria | Q85648714 |
| P2093 | author name string | Rahul Vats | |
| Punna Rao Ravi | |||
| N Aditya | |||
| Srinivas Malekar | |||
| P2860 | cites work | An estimate of the worldwide prevalence and disability associated with osteoporotic fractures | Q36597363 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanoparticle | Q61231 |
| P304 | page(s) | 114-124 | |
| P577 | publication date | 2013-12-28 | |
| P1433 | published in | European Journal of Pharmaceutics and Biopharmaceutics | Q5412740 |
| P1476 | title | Lipid nanoparticles for oral delivery of raloxifene: optimization, stability, in vivo evaluation and uptake mechanism | |
| P478 | volume | 87 |
| Q99403570 | A Non-Lipolysis Nanoemulsion Improved Oral Bioavailability by Reducing the First-Pass Metabolism of Raloxifene, and Related Absorption Mechanisms Being Studied |
| Q48273811 | Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks. |
| Q51824391 | Cuboidal lipid polymer nanoparticles of rosuvastatin for oral delivery. |
| Q55476473 | Development and Characterization of Solid Lipid Nanoparticles Containing Herbal Extract: In Vivo Antidepressant Activity. |
| Q38608263 | From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity. |
| Q90661362 | Influence of PEGylation of Vitamin-K-Loaded Mixed Micelles on the Uptake by and Transport through Caco-2 Cells |
| Q38862706 | Nanoparticles for oral delivery: Design, evaluation and state-of-the-art |
| Q36870135 | Nanostructured lipid carriers for oral bioavailability enhancement of raloxifene: Design and in vivo study |
| Q58738523 | Oleic Acid Nanovesicles of Minoxidil for Enhanced Follicular Delivery |
| Q47784707 | Oral bioavailability enhancement of raloxifene by developing microemulsion using D-optimal mixture design: optimization and in-vivo pharmacokinetic study. |
| Q38835047 | Raloxifene nanomicelles reduce the growth of castrate-resistant prostate cancer. |
| Q89350696 | Raloxifene/SBE-β-CD Inclusion Complexes Formulated into Nanoparticles with Chitosan to Overcome the Absorption Barrier for Bioavailability Enhancement |
| Q90675994 | Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages |
| Q42220432 | Synthetic surfactant- and cross-linker-free preparation of highly stable lipid-polymer hybrid nanoparticles as potential oral delivery vehicles |
Search more.